Envision Healthcare Corporation (NYSE:EVHC) updated its FY17 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of $3.35-3.45 for the period, compared to the Thomson Reuters consensus estimate of $3.45. The company issued revenue guidance of $7.75-8.0 billion, compared to the consensus revenue estimate of $7.96 billion.Envision Healthcare Corporation also updated its Q3 guidance to $0.87-0.83 EPS.

Several research firms recently issued reports on EVHC. Cantor Fitzgerald reissued a buy rating on shares of Envision Healthcare Corporation in a research report on Monday, July 24th. Royal Bank Of Canada increased their target price on Envision Healthcare Corporation from $72.00 to $77.00 and gave the stock an outperform rating in a research report on Tuesday, June 27th. Zacks Investment Research raised Envision Healthcare Corporation from a strong sell rating to a buy rating and set a $70.00 target price on the stock in a research report on Tuesday, July 4th. Canaccord Genuity reaffirmed a buy rating and issued a $86.00 target price on shares of Envision Healthcare Corporation in a research report on Tuesday, April 18th. Finally, BidaskClub raised Envision Healthcare Corporation from a sell rating to a hold rating in a research report on Saturday, June 17th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of Buy and an average target price of $71.89.

Envision Healthcare Corporation (NYSE:EVHC) traded down 1.33% on Monday, hitting $55.05. The stock had a trading volume of 2,272,795 shares. The firm’s market cap is $6.39 billion. Envision Healthcare Corporation has a 1-year low of $53.12 and a 1-year high of $74.75. The firm’s 50-day moving average price is $60.18 and its 200-day moving average price is $61.73.

In other news, insider Robert Jon Coward sold 1,500 shares of the business’s stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $62.69, for a total transaction of $94,035.00. Following the completion of the sale, the insider now owns 97,863 shares in the company, valued at $6,135,031.47. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 3.10% of the company’s stock.

WARNING: “Envision Healthcare Corporation (NYSE:EVHC) Releases FY17 Earnings Guidance” was originally posted by American Banking News and is the sole property of of American Banking News. If you are reading this piece on another domain, it was stolen and reposted in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.americanbankingnews.com/2017/08/07/envision-healthcare-corporation-nyseevhc-releases-fy17-earnings-guidance.html.

About Envision Healthcare Corporation

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.